Cite
HARVARD Citation
Reardon, D. et al. (n.d.). ATIM-29. A PHASE 1 STUDY OF PF-06840003, AN ORAL INDOLE 2, 3-DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH MALIGNANT GLIOMAS. Neuro-oncology. p. vi32. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reardon, D. et al. (n.d.). ATIM-29. A PHASE 1 STUDY OF PF-06840003, AN ORAL INDOLE 2, 3-DIOXYGENASE 1 (IDO1) INHIBITOR IN PATIENTS WITH MALIGNANT GLIOMAS. Neuro-oncology. p. vi32. [Online].